A recent meta-analysis of randomized clinical trials by Leombruno and colleagues, however, did not find an increased risk of serious infections in RA patients treated with recommended doses of anti-TNF-α therapies [16]. The gene discussed is TNF; the disease is rheumatoid arthritis.